Journals / Göztepe Tıp Dergisi / 2008 / Cilt: 23 - Sayı: 4

Association between specific measurement indexes of ankylosing spondylits and demographic data

Ankilozan spondilit’li hastalarda BASFI, BASDAI, BASMI, BASRI indeksleri ve ilişkili parametreler

Pages
112–117
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Income level was found as a second parameter related with BASMI, BASRI and as well with BASFI.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To determine the association between specific measurement indexes of ankylosing spondylitis (AS) and demographic data.
📊
Key Findings & Data:Patients and Method: 83 patient (29 female, 54 male) who are followed in our outpatient clinic and diagnosed as AS according to modified New York criteria were included into the study.
💡
Conclusion & Impact:Income level was found as a second parameter related with BASMI, BASRI and as well with BASFI.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To determine the association between specific measurement indexes of ankylosing spondylitis (AS) and demographic data. Patients and Method: 83 patient (29 female, 54 male) who are followed in our outpatient clinic and diagnosed as AS according to modified New York criteria were included into the study. Exercise programs, smoking, medications, comorbidities, income levels, and duration of the diseases were queried. Specific measurement indexes of AS; Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Disease Activation Index (BASDAI), Bath Ankylosing Spondylitis Metrology Index (BASMI), Bath Ankylosing Spondylitis Radiologic Index (BASRI) were scaled. Results: Avarage age range of patients were 41.1±9.7 (24-62) years. Avarage disease duration was 8.2±5.6 (1-34) years. 28 (33.7 %), 8 (9.6 %), 47 (56.6 %) of the patients stated that they were exercising regularly, irregularly and not at all, respectively. 31 (37.3 %) of the patients were smokers. 67 (80.7 %) of the patients has had no comorbidities. Patients using Non-steroidal anti-inflammotory drugs (NSAID); NSAID+ Sulfasalazin, and/or Methotrexate; anti-tumor necrosis factor alfa (anti-TNF) were respectively 31 (37.3 %), 30 (36.1 %), 17 (20.5 %). Ranged according to the income level; 28 (33.7 %) of the patients were earning 550 YTL and lesser, 37 (44.6 %) were earning 550-1000 YTL, 18 (21.7 %) were earning 1000 YTL and more. No relevant statistical relation between exercise & smoking, and BASFI, BASDAI, BASMI, BASRI was detected. Relavant negative correlation (p:0.012, p:0.0001, p:0.002) was detected between income level and BASFI, BASMI, BASRI. Statistically relevant relation was detected between disease duration and BASMI and BASRI (p:0.001, p:0.005) whereas no relation between BASFI and BASDAI was detected. Conclusion: Disease duration in AS was detected as an important parameter related with BASMI and BASRI. Income level was found as a second parameter related with BASMI, BASRI and as well with BASFI.

Özet

Amaç: Ankilozan Spondilit’e (AS) özgü ölçüm indeksleri ile demografik veriler arasındaki ilişkiyi saptamak.Materyal ve Metod: Çalışmaya polikliniğimizde takip edilen, modifiye New York kriterlerine göre AS tanısı almış 83 hasta dahil edildi (29 kadın, 54 erkek). Egzersiz programları, sigara kullanımları, ilaçları, ek hastalıkları, gelir düzeyleri ve hastalık süreleri sorgulandı. AS’e özgü değerlendirme indeksleri olan Bath Ankilozan Spondilit Fonksiyonel İndeksi (BASFI), Bath Ankilozan Spondilit Hastalık Aktivite İndeksi (BASDAI), Bath Ankilozan Spondilit Metroloji İndeksi (BASMI), Bath Ankilozan Spondilit Radyoloji İndeksi (BASRI) hesaplandı.Bulgular: Hastaların yaş ortalamaları 41.1±9.7 (24-62 yaş) yıldı. Ortalama hastalık süresi 8.2 ± 5.6 yıldı. 28’i (% 33.7) düzenli, 8’i (% 9.6) düzensiz egzersiz yaptığını, 47’si (% 56.6) egzersiz yapmadıklarını belirttiler. 31 (% 37.3) kişi sigara kullanıyordu. 67 (% 80.7) olguda ek bir hastalık yoktu. Non-steroid antiinflamatuar ilaç (NSAI); NSAI+Sulfasalazin ve/veya Methotrexate; anti tümör nekroz faktör alfa (anti-TNF) alan hastaların dağılımı sırayla; 31 (% 37.3), 30 (% 36.1), 17 (% 20.5) idi. Gelir düzeyine göre gruplandırıldıklarında; 550 YTL ve altı 28 (% 33.7) kişi, 550-1000 YTL arası 37 (% 44.6) kişi, 1000 YTL ve üzeri olanlar 18 (% 21.7) kişi idi. Egzersizin ve sigara kullanımının BASFI, BASDAI, BASMI, BASRI ile arasında istatistiksel olarak anlamlı bir ilişkisi saptanmadı. Gelir düzeyleri ile BASFI, BASMI, BASRI değerleri arasında anlamlı negatif korelasyon bulundu (p:0.012, p:0.0001, p:0.002). Hastalık süresi ile BASMI ve BASRI arasında istatistiksel olarak anlamlı ilişki bulunurken (p:0.001, p:0.005), BASFI ve BASDAI ile bulunmadı.Sonuç: AS’de hastalık süresi, BASMI ve BASRI ile ilişkili önemli bir parametre olarak saptandı. Gelir düzeyi ise BASMI, BASRI ile birlikte BASFI ile de ilişkili ikinci bir parametre olarak bulundu.

🔖

Cite This Article

YUMUŞAKHUYLU, Y., AKPINAR, P., KOLUKISA, Ş., OĞUZ, M. F., ARAS, H., İÇAĞASIĞLU, A. (2022). Association between specific measurement indexes of ankylosing spondylits and demographic data. Göztepe Tıp Dergisi, Cilt: 23 - Sayı: 4, 112–117. https://ajindex.com/articles/526257

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Arnett FC. Ankylosing spondylitis. In Kopman WJ (ed): Arthritis and allied conditions. 14th ed. Philadelphia: Lippincot, Williams&Williams, 1311-23, 2001
  2. Ward MM. Health-related quality of life in ankylosing spondilitis: A survey of 175 patients. Arthritis Care Res 1999;12:247-55
  3. Kamil Yazıcıoğlu, A. Salim Göktepe, Bilge Yılmaz ve ark. Ankilozan Spondilitli hastaların değerlendirilmesinde BATH indexleri Romatizma, 2003;2:18
  4. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath ankylosing spondylitis functional index. J Rheumatol 1994;21(12):2281-5
  5. Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: The Bath ankylosing spondylitis disease activitiy index. J Rheumatol 1994; 21(12):2286-91
  6. Jenkinson TR, Mallorie PA, Whitelock HC, et al. Defining spinal mobility in ankylosing spondylitis (AS). The Bath as metrology index. J Rheumatol 1994;21(9):1694-8
  7. MacKay K, Mack C, Brophy S, et al. The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum 1998;41(12):2263-70
  8. Henk SG, Malcolm MS, Sjef ML, et al. Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Roma, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheumatol 1985;24:242-9
  9. Ajda Bal, Rahime Depedibi, Ece Aydoğ ve ark. Ankilozan spondilitli hastalarda hastalık aktivitesi ve fonksiyonel durumun beş yıllık değişimi. FTR Bil Der J PMR Sci 2007;3:80-83
  10. Analay Y, Ozcan E, Karan A, ve ark. The effectiveness of intensive group exercise on patients with ankylosing spondylitis. Clin Rehabil 2003;17:631-636
  11. Kraag G, Stokes B, Groh J, et al. The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis; a randomized controlled trial. J Rheumatol 1990;17:228-233
  12. Sweeney S, Taylor G, Calin A. The effect of a home based exercise intervention package on outcome in ankylosing spondylitis: a randomized controlled trial. J Rheumatol 2002;29:763-766
  13. Dagfinrud H, Kvien TK, Hagen KB. The Cochrane review of physiotherapy interventions for ankylosing spondylitis. J Rheumatol 2005; 32:1899-906
  14. Hidding A, van der Linden S, Boers M, et al. Is group physical therapy superior to individualized therapy in ankylosing s